Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Baseline quality of life predicts overall survival in patients with mCRPC treated with 223Ra-dichloride.

Frantellizzi V, De Feo MS, Di Rocco A, Pontico M, Pani A, Farcomeni A, Cosma L, Lazri J, De Vincentis G.

Hell J Nucl Med. 2020 Mar 31. pii: s002449912001. doi: 10.1967/s002449912001. [Epub ahead of print]

PMID:
32222727
2.

Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study.

Morello L, Rattotti S, Giordano L, Jerkeman M, van Meerten T, Krawczyk K, Moita F, Marino D, Ferrero S, Szymczyk M, Aurer I, El-Galaly TC, Di Rocco A, Visco C, Carli G, Defrancesco I, Carlo-Stella C, Dreyling M, Santoro A, Arcaini L.

Hemasphere. 2019 Dec 16;4(1):e302. doi: 10.1097/HS9.0000000000000302. eCollection 2020 Feb.

3.

New Insights and Methods in the Approach to Thalassemia Major: The Lesson From the Case of Adrenal Insufficiency.

Poggi M, Samperi I, Mattia L, Di Rocco A, Iorio C, Monti S, Pugliese G, Toscano V.

Front Mol Biosci. 2020 Jan 29;6:162. doi: 10.3389/fmolb.2019.00162. eCollection 2019.

4.

Standardized EEG analysis to reduce the uncertainty of outcome prognostication after cardiac arrest.

Bongiovanni F, Romagnosi F, Barbella G, Di Rocco A, Rossetti AO, Taccone FS, Sandroni C, Oddo M.

Intensive Care Med. 2020 Feb 3. doi: 10.1007/s00134-019-05921-6. [Epub ahead of print]

PMID:
32016534
5.

MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL).

Tisi MC, Ferrero S, Dogliotti I, Tecchio C, Carli G, Novo M, Stefani PM, Rattotti S, Balzarotti M, Marino D, Pelosini M, Romano A, Flenghi L, Zilioli VR, Calimeri T, Di Napoli A, Zanni M, Finolezzi E, Mosna F, Gini G, Mansueto G, Di Rocco A, Tomei G, Sgherza N, Olivieri J, Nassi L, Piazza F, Fama A, Greco A, Giannoccaro M, Mazzone AM, Visco C, Loseto G, Zaja F.

Hemasphere. 2019 Oct 22;3(6):e305. doi: 10.1097/HS9.0000000000000305. eCollection 2019 Dec.

6.

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.

Poeschel V, Held G, Ziepert M, Witzens-Harig M, Holte H, Thurner L, Borchmann P, Viardot A, Soekler M, Keller U, Schmidt C, Truemper L, Mahlberg R, Marks R, Hoeffkes HG, Metzner B, Dierlamm J, Frickhofen N, Haenel M, Neubauer A, Kneba M, Merli F, Tucci A, de Nully Brown P, Federico M, Lengfelder E, di Rocco A, Trappe R, Rosenwald A, Berdel C, Maisenhoelder M, Shpilberg O, Amam J, Christofyllakis K, Hartmann F, Murawski N, Stilgenbauer S, Nickelsen M, Wulf G, Glass B, Schmitz N, Altmann B, Loeffler M, Pfreundschuh M; FLYER Trial Investigators; German Lymphoma Alliance.

Lancet. 2020 Dec 21;394(10216):2271-2281. doi: 10.1016/S0140-6736(19)33008-9.

PMID:
31868632
7.

Prognostic impact of somatic mutations in diffuse large B-cell lymphoma and relationship to cell-of-origin: data from the phase III GOYA study.

Bolen CR, Klanova M, Trneny M, Sehn LH, He J, Tong J, Paulson JN, Kim E, Vitolo U, Di Rocco A, Fingerle-Rowson G, Nielsen T, Lenz G, Oestergaard MZ.

Haematologica. 2019 Nov 14. pii: haematol.2019.227892. doi: 10.3324/haematol.2019.227892. [Epub ahead of print]

8.

Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network.

Ciccarone M, Hohaus S, Pulsoni A, Cavaceppi P, Franzò S, Fabbri R, Cudillo L, Battistini R, Di Rocco A, Annibali O, Cox MC, Provenzano I, Abruzzese E, Renzi D, Tesei C, Anticoli Borza P, Cuccaro A, Andriani A, D'Elia GM, Facchiano A, Marchetti P, Cantonetti M.

Eur J Cancer Care (Engl). 2020 Jan;29(1):e13174. doi: 10.1111/ecc.13174. Epub 2019 Sep 30.

PMID:
31571303
9.

KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study.

Ferrero S, Rossi D, Rinaldi A, Bruscaggin A, Spina V, Eskelund CW, Evangelista A, Moia R, Kwee I, Dahl C, Di Rocco A, Stefoni V, Diop F, Favini C, Ghione P, Mahmoud AM, Schipani M, Kolstad A, Barbero D, Novero D, Paulli M, Zamò A, Jerkeman M, Gomez da Silva M, Santoro A, Molinari A, Ferreri A, Grønbæk K, Piccin A, Cortelazzo S, Bertoni F, Ladetto M, Gaidano G.

Haematologica. 2019 Sep 19. pii: haematol.2018.214056. doi: 10.3324/haematol.2018.214056. [Epub ahead of print]

10.

Sex-related differences in homebound advanced Parkinson's disease patients.

Nwabuobi L, Barbosa W, Sweeney M, Oyler S, Meisel T, Di Rocco A, Chodosh J, Fleisher JE.

Clin Interv Aging. 2019 Jul 31;14:1371-1377. doi: 10.2147/CIA.S203690. eCollection 2019.

11.

Effects of rTMS and intensive rehabilitation in Parkinson's Disease on learning and retention.

Marchesi G, Albanese GA, Ferrazzoli D, George S, Ricci S, Tatti E, Di Rocco A, Quartarone A, Frazzitta G, Ghilardi MF.

IEEE Int Conf Rehabil Robot. 2019 Jun;2019:1260-1265. doi: 10.1109/ICORR.2019.8779471.

PMID:
31374802
12.

Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma.

Ferretti A, Baldacci E, Miulli E, Canichella M, Di Rocco A, Pulsoni A, Martelli M, Serrao A, Chistolini A, Gabriella Mazzucconi M, Foà R, Santoro C.

Br J Haematol. 2019 Sep;186(6):e217-e219. doi: 10.1111/bjh.16114. Epub 2019 Jul 31. No abstract available.

PMID:
31364154
13.

Altered dynamics of visual contextual interactions in Parkinson's disease.

Vanegas MI, Blangero A, Galvin JE, Di Rocco A, Quartarone A, Ghilardi MF, Kelly SP.

NPJ Parkinsons Dis. 2019 Jul 4;5:13. doi: 10.1038/s41531-019-0085-5. eCollection 2019.

14.

The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network 'Rete Ematologica del Lazio per i Linfomi' (RELLI).

Annibali O, Hohaus S, Marchesi F, Cantonetti M, Di Rocco A, Tomarchio V, Di Napoli A, Pelliccia S, Battistini R, Anticoli Borza P, Abruzzese E, Cenfra N, Andriani A, Tesei C, Alma E, Palombi F, Pupo L, Petrucci L, Becilli M, Maiolo E, Bellesi S, Cuccaro A, D'Alò F, Cox MC.

Leuk Lymphoma. 2019 Dec;60(14):3386-3394. doi: 10.1080/10428194.2019.1633628. Epub 2019 Jul 1.

PMID:
31259651
15.

Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients.

Proietti M, Farcomeni A, Romiti GF, Di Rocco A, Placentino F, Diemberger I, Lip GY, Boriani G.

Eur J Prev Cardiol. 2018 Dec 6:2047487318817662. doi: 10.1177/2047487318817662. [Epub ahead of print]

PMID:
30861693
16.

Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma.

Maura F, Agnelli L, Leongamornlert D, Bolli N, Chan WC, Dodero A, Carniti C, Heavican TB, Pellegrinelli A, Pruneri G, Butler A, Bhosle SG, Chiappella A, Di Rocco A, Zinzani PL, Zaja F, Piva R, Inghirami G, Wang W, Palomero T, Iqbal J, Neri A, Campbell PJ, Corradini P.

Am J Hematol. 2019 Jun;94(6):628-634. doi: 10.1002/ajh.25450. Epub 2019 Mar 19.

17.

Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas.

Merli M, Frigeni M, Alric L, Visco C, Besson C, Mannelli L, Di Rocco A, Ferrari A, Farina L, Pirisi M, Piazza F, Loustaud-Ratti V, Arcari A, Marino D, Sica A, Goldaniga M, Rusconi C, Gentile M, Cencini E, Benanti F, Rumi MG, Ferretti VV, Grossi P, Gotti M, Sciarra R, Tisi MC, Cano I, Zuccaro V, Passamonti F, Arcaini L.

Oncologist. 2019 Aug;24(8):e720-e729. doi: 10.1634/theoncologist.2018-0331. Epub 2018 Dec 14.

18.

Coronary atherosclerosis in apparently healthy master athletes discovered during pre-PARTECIPATION screening. Role of coronary CT angiography (CCTA).

Gervasi SF, Palumbo L, Cammarano M, Orvieto S, Di Rocco A, Vestri A, Marano R, Savino G, Bianco M, Zeppilli P, Palmieri V.

Int J Cardiol. 2019 May 1;282:99-107. doi: 10.1016/j.ijcard.2018.11.099. Epub 2018 Nov 20.

PMID:
30482442
19.

Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.

Visco C, Tisi MC, Evangelista A, Di Rocco A, Zoellner AK, Zilioli VR, Hohaus S, Sciarra R, Re A, Tecchio C, Chiappella A, Morello L, Gini G, Nassi L, Perrone T, Molinari AL, Fabbri A, Cox MC, Finolezzi E, Ferrero S, Puccini B, Alvarez De Celis I, Arcari A, Marino D, Merli M, Piazza F, Gentile M, Pelosini M, Loseto G, Hermine O, Dreyling M, Ruggeri M, Martelli M, Hoster E, Vitolo U; Fondazione Italiana Linfomi and the Mantle Cell Lymphoma Network.

Br J Haematol. 2019 Jun;185(5):940-944. doi: 10.1111/bjh.15643. Epub 2018 Nov 8. No abstract available.

PMID:
30407625
20.

Visuospatial exploration and art therapy intervention in patients with Parkinson's disease: an exploratory therapeutic protocol.

Cucca A, Acosta I, Berberian M, Lemen AC, Rizzo JR, Ghilardi MF, Quartarone A, Feigin AS, Di Rocco A, Biagioni MC.

Complement Ther Med. 2018 Oct;40:70-76. doi: 10.1016/j.ctim.2018.07.011. Epub 2018 Jul 27.

21.

Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo.

Ciccarelli C, Di Rocco A, Gravina GL, Mauro A, Festuccia C, Del Fattore A, Berardinelli P, De Felice F, Musio D, Bouché M, Tombolini V, Zani BM, Marampon F.

J Cancer Res Clin Oncol. 2018 Sep;144(9):1685-1699. doi: 10.1007/s00432-018-2696-3. Epub 2018 Jun 29.

PMID:
29959569
22.

Outcomes of intradetrusor onabotulinum toxin A injection in patients with Parkinson's disease.

Vurture G, Peyronnet B, Feigin A, Biagioni MC, Gilbert R, Rosenblum N, Frucht S, Di Rocco A, Nitti VW, Brucker BM.

Neurourol Urodyn. 2018 Nov;37(8):2669-2677. doi: 10.1002/nau.23717. Epub 2018 May 16.

PMID:
29767449
23.

Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma.

Ceriani L, Milan L, Martelli M, Ferreri AJM, Cascione L, Zinzani PL, Di Rocco A, Conconi A, Stathis A, Cavalli F, Bellei M, Cozens K, Porro E, Giovanella L, Johnson PW, Zucca E.

Blood. 2018 Jul 12;132(2):179-186. doi: 10.1182/blood-2018-01-826958. Epub 2018 May 2.

PMID:
29720487
24.

Locally advanced squamous cell carcinoma of the head and neck: A systematic review and Bayesian network meta-analysis of the currently available treatment options.

Iocca O, Farcomeni A, Di Rocco A, Di Maio P, Golusinski P, Pardiñas López S, Savo A, Pellini R, Spriano G.

Oral Oncol. 2018 May;80:40-51. doi: 10.1016/j.oraloncology.2018.03.001. Epub 2018 Mar 27.

PMID:
29706187
25.

Comorbid Normal Pressure Hydrocephalus with Parkinsonism: A Clinical Challenge and Call for Awareness.

Cucca A, Biagioni MC, Sharma K, Golomb J, Gilbert RM, Di Rocco A, Fleisher JE.

Case Rep Neurol Med. 2018 Jan 21;2018:2513474. doi: 10.1155/2018/2513474. eCollection 2018.

26.

Interdisciplinary Home Visits for Individuals with Advanced Parkinson's Disease and Related Disorders.

Fleisher J, Barbosa W, Sweeney MM, Oyler SE, Lemen AC, Fazl A, Ko M, Meisel T, Friede N, Dacpano G, Gilbert RM, Di Rocco A, Chodosh J.

J Am Geriatr Soc. 2018 Jul;66(6):1226-1232. doi: 10.1111/jgs.15337. Epub 2018 Apr 2.

27.

BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant.

Marchesi F, Capria S, Giannarelli D, Trisolini SM, Ansuinelli M, Caputo MD, Serrao A, Gumenyuk S, Renzi D, Pupo L, Palombi F, Provenzano I, Di Rocco A, Pisani F, Romano A, Spadea A, Papa E, Canfora M, Cantonetti M, Mengarelli A.

Bone Marrow Transplant. 2018 Aug;53(8):1051-1054. doi: 10.1038/s41409-018-0120-x. Epub 2018 Feb 13. No abstract available.

PMID:
29440737
28.

Hormone-induced DNA damage response and repair mediated by cyclin D1 in breast and prostate cancer.

Di Sante G, Di Rocco A, Pupo C, Casimiro MC, Pestell RG.

Oncotarget. 2017 Jul 20;8(47):81803-81812. doi: 10.18632/oncotarget.19413. eCollection 2017 Oct 10. Review.

29.

Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth.

Pestell TG, Jiao X, Kumar M, Peck AR, Prisco M, Deng S, Li Z, Ertel A, Casimiro MC, Ju X, Di Rocco A, Di Sante G, Katiyar S, Shupp A, Lisanti MP, Jain P, Wu K, Rui H, Hooper DC, Yu Z, Goldman AR, Speicher DW, Laury-Kleintop L, Pestell RG.

Oncotarget. 2017 Aug 4;8(47):81754-81775. doi: 10.18632/oncotarget.19953. eCollection 2017 Oct 10.

30.

Cognitive performance in mid-stage Parkinson's disease: functional connectivity under chronic antiparkinson treatment.

Vancea R, Simonyan K, Petracca M, Brys M, Di Rocco A, Ghilardi MF, Inglese M.

Brain Imaging Behav. 2019 Feb;13(1):200-209. doi: 10.1007/s11682-017-9765-0.

31.

Are we missing non-motor seizures in Parkinson's disease? Two case reports.

Son AY, Cucca A, Agarwal S, Liu A, Di Rocco A, Biagioni MC.

J Clin Mov Disord. 2017 Sep 5;4:14. doi: 10.1186/s40734-017-0061-3. eCollection 2017.

32.

Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case.

Santoro C, Volpicelli P, Baldacci E, Ferrara G, Di Rocco A, Ferretti A, Porrazzo M, Mazzucconi MG.

Clin Case Rep. 2017 Jul 13;5(8):1385-1388. doi: 10.1002/ccr3.920. eCollection 2017 Aug.

33.

Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.

Broccoli A, Pellegrini C, Di Rocco A, Puccini B, Patti C, Gini G, Mannina D, Tani M, Rusconi C, Romano A, Vanazzi A, Botto B, Carlo-Stella C, Hohaus S, Musto P, Mazza P, Molica S, Corradini P, Fama A, Gaudio F, Merli M, Gravetti A, Gritti G, Arcari A, Tosi P, Liberati AM, Pinto A, Pavone V, Gherlinzoni F, Naso V, Volpetti S, Trentin L, Goldaniga MC, Bonfichi M, De Renzo A, Schiavotto C, Spina M, Storti S, Carella AM, Stefoni V, Argnani L, Zinzani PL.

Haematologica. 2017 Nov;102(11):1931-1935. doi: 10.3324/haematol.2017.171355. Epub 2017 Aug 3.

34.

Infection-mediated autoimmune movement disorders.

Cucca A, Migdadi HA, Di Rocco A.

Parkinsonism Relat Disord. 2018 Jan;46 Suppl 1:S83-S86. doi: 10.1016/j.parkreldis.2017.07.019. Epub 2017 Jul 21. Review.

PMID:
28756176
35.

Is now the time for molecular driven therapy for diffuse large B-cell lymphoma?

Di Rocco A, De Angelis F, Ansuinelli M, Foà R, Martelli M.

Expert Rev Hematol. 2017 Sep;10(9):761-774. doi: 10.1080/17474086.2017.1356714. Epub 2017 Jul 25. Review.

PMID:
28712322
36.

Cyclin D1 Restrains Oncogene-Induced Autophagy by Regulating the AMPK-LKB1 Signaling Axis.

Casimiro MC, Di Sante G, Di Rocco A, Loro E, Pupo C, Pestell TG, Bisetto S, Velasco-Velázquez MA, Jiao X, Li Z, Kusminski CM, Seifert EL, Wang C, Ly D, Zheng B, Shen CH, Scherer PE, Pestell RG.

Cancer Res. 2017 Jul 1;77(13):3391-3405. doi: 10.1158/0008-5472.CAN-16-0425. Epub 2017 May 18.

37.

Role of bone marrow biopsy in staging of patients with classical Hodgkin's lymphoma undergoing positron emission tomography/computed tomography.

Puccini B, Nassi L, Minoia C, Volpetti S, Ciancia R, Riccomagno PC, Di Rocco A, Mulè A, Toldo C, Sassone MC, Guariglia R, Filì C, Finolezzi E, Falorio S, Zanon S, Furlan A, Doa G, Zaja F; Fondazione Italiana Linfomi Postgraduate Master course.

Ann Hematol. 2017 Jul;96(7):1147-1153. doi: 10.1007/s00277-017-2996-8. Epub 2017 Apr 28.

PMID:
28451805
38.

Beta Oscillatory Changes and Retention of Motor Skills during Practice in Healthy Subjects and in Patients with Parkinson's Disease.

Nelson AB, Moisello C, Lin J, Panday P, Ricci S, Canessa A, Di Rocco A, Quartarone A, Frazzitta G, Isaias IU, Tononi G, Cirelli C, Ghilardi MF.

Front Hum Neurosci. 2017 Mar 7;11:104. doi: 10.3389/fnhum.2017.00104. eCollection 2017.

39.

Primary mediastinal large B-cell lymphoma.

Martelli M, Ferreri A, Di Rocco A, Ansuinelli M, Johnson PWM.

Crit Rev Oncol Hematol. 2017 May;113:318-327. doi: 10.1016/j.critrevonc.2017.01.009. Epub 2017 Jan 21. Review.

PMID:
28318892
40.

Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial.

Zinzani PL, Pellegrini C, Chiappella A, Di Rocco A, Salvi F, Cabras MG, Argnani L, Stefoni V.

Blood. 2017 Apr 20;129(16):2328-2330. doi: 10.1182/blood-2017-01-764258. Epub 2017 Mar 6. No abstract available.

PMID:
28264798
41.

Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy: Results from a monoinstitutional cohort analysis of long-term survivors.

De Sanctis V, Alfò M, Di Rocco A, Ansuinelli M, Russo E, Osti MF, Valeriani M, Minniti G, Grapulin L, Musio D, Bracci S, Spagnoli A, Moleti ML, Tombolini V, Martelli M.

Hematol Oncol. 2017 Dec;35(4):554-560. doi: 10.1002/hon.2377. Epub 2017 Jan 12.

PMID:
28078727
42.

v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1.

Ju X, Jiao X, Ertel A, Casimiro MC, Di Sante G, Deng S, Li Z, Di Rocco A, Zhan T, Hawkins A, Stoyanova T, Andò S, Fatatis A, Lisanti MP, Gomella LG, Languino LR, Pestell RG.

Cancer Res. 2016 Nov 15;76(22):6723-6734. doi: 10.1158/0008-5472.CAN-15-3327. Epub 2016 Sep 15.

43.

Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease: A randomized trial.

Brys M, Fox MD, Agarwal S, Biagioni M, Dacpano G, Kumar P, Pirraglia E, Chen R, Wu A, Fernandez H, Wagle Shukla A, Lou JS, Gray Z, Simon DK, Di Rocco A, Pascual-Leone A.

Neurology. 2016 Nov 1;87(18):1907-1915. Epub 2016 Oct 5.

44.

Parkinson's Disease and Cryptogenic Epilepsy.

Son AY, Biagioni MC, Kaminski D, Gurevich A, Stone B, Di Rocco A.

Case Rep Neurol Med. 2016;2016:3745631. doi: 10.1155/2016/3745631. Epub 2016 Sep 5.

45.

Freezing of gait in Parkinson's disease: from pathophysiology to emerging therapies.

Cucca A, Biagioni MC, Fleisher JE, Agarwal S, Son A, Kumar P, Brys M, Di Rocco A.

Neurodegener Dis Manag. 2016 Oct;6(5):431-46. doi: 10.2217/nmt-2016-0018. Epub 2016 Sep 7. Review.

PMID:
27599588
46.

The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study.

Zinzani PL, Rigacci L, Cox MC, Devizzi L, Fabbri A, Zaja F, Di Rocco A, Rossi G, Storti S, Fattori PP, Argnani L, Vitolo U.

Leuk Lymphoma. 2017 Jan;58(1):226-229. Epub 2016 Jun 2. No abstract available.

PMID:
27252040
47.

Randomized, Double-Blind, Phase III Trial of Enzastaurin Versus Placebo in Patients Achieving Remission After First-Line Therapy for High-Risk Diffuse Large B-Cell Lymphoma.

Crump M, Leppä S, Fayad L, Lee JJ, Di Rocco A, Ogura M, Hagberg H, Schnell F, Rifkin R, Mackensen A, Offner F, Pinter-Brown L, Smith S, Tobinai K, Yeh SP, Hsi ED, Nguyen T, Shi P, Hahka-Kemppinen M, Thornton D, Lin B, Kahl B, Schmitz N, Savage KJ, Habermann T.

J Clin Oncol. 2016 Jul 20;34(21):2484-92. doi: 10.1200/JCO.2015.65.7171. Epub 2016 May 23.

PMID:
27217449
48.

c-Myc Sustains Transformed Phenotype and Promotes Radioresistance of Embryonal Rhabdomyosarcoma Cell Lines.

Gravina GL, Festuccia C, Popov VM, Di Rocco A, Colapietro A, Sanità P, Monache SD, Musio D, De Felice F, Di Cesare E, Tombolini V, Marampon F.

Radiat Res. 2016 Apr;185(4):411-22. doi: 10.1667/RR14237.1.

PMID:
27104757
49.

Practice changes beta power at rest and its modulation during movement in healthy subjects but not in patients with Parkinson's disease.

Moisello C, Blanco D, Lin J, Panday P, Kelly SP, Quartarone A, Di Rocco A, Cirelli C, Tononi G, Ghilardi MF.

Brain Behav. 2015 Sep 23;5(10):e00374. doi: 10.1002/brb3.374. eCollection 2015 Oct.

50.

Intensive Rehabilitation Enhances Lymphocyte BDNF-TrkB Signaling in Patients With Parkinson's Disease.

Fontanesi C, Kvint S, Frazzitta G, Bera R, Ferrazzoli D, Di Rocco A, Rebholz H, Friedman E, Pezzoli G, Quartarone A, Wang HY, Ghilardi MF.

Neurorehabil Neural Repair. 2016 Jun;30(5):411-8. doi: 10.1177/1545968315600272. Epub 2015 Aug 7.

Supplemental Content

Loading ...
Support Center